These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8104473)

  • 1. Transcriptional and post-transcriptional mechanisms are involved in the absence of CD4 surface expression in two HIV-1 chronically infected T cell lines.
    Serpente N; Hemar A; Cefai D; Dautry-Varsat A; Fagard R; Fischer S; Vaquero C
    Int Immunol; 1993 Aug; 5(8):939-47. PubMed ID: 8104473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum.
    Crise B; Rose JK
    J Virol; 1992 Apr; 66(4):2296-301. PubMed ID: 1548763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ick protein tyrosine kinase is not involved in antibody-mediated CD4 (CDR3-loop) signal transduction that inhibits HIV-1 transcription.
    Coudronnière N; Corbeil J; Robert-Hebmann V; Mesnard JM; Devaux C
    Eur J Immunol; 1998 May; 28(5):1445-57. PubMed ID: 9603449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.
    Polydefkis M; Koenig S; Flexner C; Obah E; Gebo K; Chakrabarti S; Earl PL; Moss B; Siliciano RF
    J Exp Med; 1990 Mar; 171(3):875-87. PubMed ID: 1968506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface down-modulation of CD4 after infection by HIV-1.
    Geleziunas R; Bour S; Wainberg MA
    FASEB J; 1994 Jun; 8(9):593-600. PubMed ID: 8005387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of T cell antigen receptor-dependent phosphorylation of CD4 in human immunodeficiency virus type 1 infected cells.
    Gaulton GN; Brass LF; Kozbor D; Pletcher CH; Hoxie JA
    J Biol Chem; 1992 Feb; 267(6):4102-9. PubMed ID: 1310988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
    Butera ST; Perez VL; Wu BY; Nabel GJ; Folks TM
    J Virol; 1991 Sep; 65(9):4645-53. PubMed ID: 1678437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
    Bour S; Boulerice F; Wainberg MA
    J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.
    Chirmule N; Goonewardena H; Pahwa S; Pasieka R; Kalyanaraman VS; Pahwa S
    J Biol Chem; 1995 Aug; 270(33):19364-9. PubMed ID: 7642615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum.
    Kimura T; Nishikawa M; Ohyama A
    J Biochem; 1994 May; 115(5):1010-20. PubMed ID: 7961587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells.
    Geleziunas R; Bour S; Wainberg MA
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():857-65. PubMed ID: 8151301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.
    Duensing TD; Fang H; Dorward DW; Pincus SH
    J Virol; 1995 Nov; 69(11):7122-31. PubMed ID: 7474132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD4 in HIV envelope-mediated pathogenesis.
    Siliciano RF
    Curr Top Microbiol Immunol; 1996; 205():159-79. PubMed ID: 8575195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of LFA-1-mediated T cell adhesion induced by the HIV envelope glycoprotein gp160 requires phosphatidylinositol-3-kinase activity.
    Mazerolles F; Barbat C; Fischer A
    Eur J Immunol; 1997 Sep; 27(9):2457-65. PubMed ID: 9341793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.